Corvel CRVL Options forfeited/expired (in dollars per share)

Options forfeited/expired (in dollars per share) at other companies

TRV

Trevi Therapeutics, Inc.TRVI

$0.00—

Healthcare Services GroupHCSG

$34.21+9.8%

TFS FinancialTFSL

$14.87-0.2%

LivaNovaLIVN

$79.49+3.6%

Q2 HoldingsQTWO

$0.00—

Jazz PharmaceuticalsJAZZ

$167.80+12.6%

Other financials

Income statement

See full

Revenue$248.5M+7.4%

Gross profit$63.0M+8.3%

Net income$31.0M+17.4%

EPS (diluted)$0.61+19.6%

Balance sheet

See full

Cash & equivalents$233.1M+36.6%

Total debt$28.1M+0.1%

Total equity$394.2M+22.4%

Total assets$643.0M+17.8%

Cash flow

See full

Operating cash flow$29.5M+28.6%

CapEx$9.2M+5.9%

Free cash flow$20.3M+42.3%

Valuation

See full

Market cap$3.03B-51.4%

Enterprise value$2.82B-53.8%

P/E27.4×-38.0×

P/S3.2×-3.8×

Profitability

See full

Gross margin24.3%+0.9pp

Net margin11.5%+0.9pp

FCF margin11.5%+1.3pp

Returns & leverage

See full

Return on equity30.8%-2.6pp

Debt / equity0.1×0.0×

Current ratio2×+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice.

The official record: Corvel’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvel's options forfeited/expired (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corvel's options forfeited/expired (in dollars per share)?: Corvel (CRVL) reported options forfeited/expired (in dollars per share) of $85.05 in Q4 2025.